Stage III Prostate Cancer
55
1
8
32
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
23 trials with published results (42%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
16.4%
9 terminated out of 55 trials
78.0%
-8.5% vs benchmark
2%
1 trials in Phase 3/4
72%
23 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (55)
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Researching the Effect of Exercise on Cancer
Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
Acupuncture Pilot Study for Cancer-related Cognitive Function
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Ask Questions (ASQ):Implementation of a Communication Intervention
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer
Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer